{"id":"https://openalex.org/W2016365699","doi":"https://doi.org/10.1021/jm0309957","title":"2-Anilino-4-(thiazol-5-yl)pyrimidine CDK Inhibitors: Synthesis, SAR Analysis, X-ray Crystallography, and Biological Activity","display_name":"2-Anilino-4-(thiazol-5-yl)pyrimidine CDK Inhibitors: Synthesis, SAR Analysis, X-ray Crystallography, and Biological Activity","publication_year":2004,"publication_date":"2004-02-07","ids":{"openalex":"https://openalex.org/W2016365699","doi":"https://doi.org/10.1021/jm0309957","mag":"2016365699","pmid":"https://pubmed.ncbi.nlm.nih.gov/15027857"},"language":"en","primary_location":{"id":"doi:10.1021/jm0309957","doi":"https://doi.org/10.1021/jm0309957","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm0309957","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5076511286","display_name":"Shudong Wang","orcid":"https://orcid.org/0000-0001-6225-5525","observed_orcids":["https://orcid.org/0000-0001-6225-5525"]},"institutions":[{"id":"https://openalex.org/I98677209","display_name":"University of Edinburgh","ror":"https://ror.org/01nrxwf90","country_code":"GB","type":"education","lineage":["https://openalex.org/I98677209"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Shudong Wang","raw_affiliation_strings":["Cyclacel Limited, James Lindsay Place, Dundee DD1 5JJ and Structural Biochemistry, The University of Edinburgh, Michael Swann Building, King's Buildings, Edinburgh, EH9 3JR, Scotland, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cyclacel Limited, James Lindsay Place, Dundee DD1 5JJ and Structural Biochemistry, The University of Edinburgh, Michael Swann Building, King's Buildings, Edinburgh, EH9 3JR, Scotland, UK","institution_ids":["https://openalex.org/I98677209"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052087935","display_name":"Christopher K. Meades","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I98677209","display_name":"University of Edinburgh","ror":"https://ror.org/01nrxwf90","country_code":"GB","type":"education","lineage":["https://openalex.org/I98677209"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Christopher Meades","raw_affiliation_strings":["Cyclacel Limited, James Lindsay Place, Dundee DD1 5JJ and Structural Biochemistry, The University of Edinburgh, Michael Swann Building, King's Buildings, Edinburgh, EH9 3JR, Scotland, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cyclacel Limited, James Lindsay Place, Dundee DD1 5JJ and Structural Biochemistry, The University of Edinburgh, Michael Swann Building, King's Buildings, Edinburgh, EH9 3JR, Scotland, UK","institution_ids":["https://openalex.org/I98677209"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108393427","display_name":"Gavin Wood","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I98677209","display_name":"University of Edinburgh","ror":"https://ror.org/01nrxwf90","country_code":"GB","type":"education","lineage":["https://openalex.org/I98677209"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Gavin Wood","raw_affiliation_strings":["Cyclacel Limited, James Lindsay Place, Dundee DD1 5JJ and Structural Biochemistry, The University of Edinburgh, Michael Swann Building, King's Buildings, Edinburgh, EH9 3JR, Scotland, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cyclacel Limited, James Lindsay Place, Dundee DD1 5JJ and Structural Biochemistry, The University of Edinburgh, Michael Swann Building, King's Buildings, Edinburgh, EH9 3JR, Scotland, UK","institution_ids":["https://openalex.org/I98677209"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047295033","display_name":"Andrew P. Osnowski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I98677209","display_name":"University of Edinburgh","ror":"https://ror.org/01nrxwf90","country_code":"GB","type":"education","lineage":["https://openalex.org/I98677209"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Andrew Osnowski","raw_affiliation_strings":["Cyclacel Limited, James Lindsay Place, Dundee DD1 5JJ and Structural Biochemistry, The University of Edinburgh, Michael Swann Building, King's Buildings, Edinburgh, EH9 3JR, Scotland, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cyclacel Limited, James Lindsay Place, Dundee DD1 5JJ and Structural Biochemistry, The University of Edinburgh, Michael Swann Building, King's Buildings, Edinburgh, EH9 3JR, Scotland, UK","institution_ids":["https://openalex.org/I98677209"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010357806","display_name":"Sian Anderson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I98677209","display_name":"University of Edinburgh","ror":"https://ror.org/01nrxwf90","country_code":"GB","type":"education","lineage":["https://openalex.org/I98677209"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Sian Anderson","raw_affiliation_strings":["Cyclacel Limited, James Lindsay Place, Dundee DD1 5JJ and Structural Biochemistry, The University of Edinburgh, Michael Swann Building, King's Buildings, Edinburgh, EH9 3JR, Scotland, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cyclacel Limited, James Lindsay Place, Dundee DD1 5JJ and Structural Biochemistry, The University of Edinburgh, Michael Swann Building, King's Buildings, Edinburgh, EH9 3JR, Scotland, UK","institution_ids":["https://openalex.org/I98677209"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079456472","display_name":"Rhoda Yuill","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I98677209","display_name":"University of Edinburgh","ror":"https://ror.org/01nrxwf90","country_code":"GB","type":"education","lineage":["https://openalex.org/I98677209"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Rhoda Yuill","raw_affiliation_strings":["Cyclacel Limited, James Lindsay Place, Dundee DD1 5JJ and Structural Biochemistry, The University of Edinburgh, Michael Swann Building, King's Buildings, Edinburgh, EH9 3JR, Scotland, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cyclacel Limited, James Lindsay Place, Dundee DD1 5JJ and Structural Biochemistry, The University of Edinburgh, Michael Swann Building, King's Buildings, Edinburgh, EH9 3JR, Scotland, UK","institution_ids":["https://openalex.org/I98677209"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101915636","display_name":"MARK P. THOMAS","orcid":"https://orcid.org/0000-0002-7648-2400","observed_orcids":["https://orcid.org/0000-0002-7648-2400"]},"institutions":[{"id":"https://openalex.org/I98677209","display_name":"University of Edinburgh","ror":"https://ror.org/01nrxwf90","country_code":"GB","type":"education","lineage":["https://openalex.org/I98677209"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Mark Thomas","raw_affiliation_strings":["Cyclacel Limited, James Lindsay Place, Dundee DD1 5JJ and Structural Biochemistry, The University of Edinburgh, Michael Swann Building, King's Buildings, Edinburgh, EH9 3JR, Scotland, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cyclacel Limited, James Lindsay Place, Dundee DD1 5JJ and Structural Biochemistry, The University of Edinburgh, Michael Swann Building, King's Buildings, Edinburgh, EH9 3JR, Scotland, UK","institution_ids":["https://openalex.org/I98677209"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033698685","display_name":"Mokdad Mezna","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I98677209","display_name":"University of Edinburgh","ror":"https://ror.org/01nrxwf90","country_code":"GB","type":"education","lineage":["https://openalex.org/I98677209"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Mokdad Mezna","raw_affiliation_strings":["Cyclacel Limited, James Lindsay Place, Dundee DD1 5JJ and Structural Biochemistry, The University of Edinburgh, Michael Swann Building, King's Buildings, Edinburgh, EH9 3JR, Scotland, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cyclacel Limited, James Lindsay Place, Dundee DD1 5JJ and Structural Biochemistry, The University of Edinburgh, Michael Swann Building, King's Buildings, Edinburgh, EH9 3JR, Scotland, UK","institution_ids":["https://openalex.org/I98677209"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108495886","display_name":"Wayne Jackson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I98677209","display_name":"University of Edinburgh","ror":"https://ror.org/01nrxwf90","country_code":"GB","type":"education","lineage":["https://openalex.org/I98677209"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Wayne Jackson","raw_affiliation_strings":["Cyclacel Limited, James Lindsay Place, Dundee DD1 5JJ and Structural Biochemistry, The University of Edinburgh, Michael Swann Building, King's Buildings, Edinburgh, EH9 3JR, Scotland, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cyclacel Limited, James Lindsay Place, Dundee DD1 5JJ and Structural Biochemistry, The University of Edinburgh, Michael Swann Building, King's Buildings, Edinburgh, EH9 3JR, Scotland, UK","institution_ids":["https://openalex.org/I98677209"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082048326","display_name":"Carol Midgley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I98677209","display_name":"University of Edinburgh","ror":"https://ror.org/01nrxwf90","country_code":"GB","type":"education","lineage":["https://openalex.org/I98677209"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Carol Midgley","raw_affiliation_strings":["Cyclacel Limited, James Lindsay Place, Dundee DD1 5JJ and Structural Biochemistry, The University of Edinburgh, Michael Swann Building, King's Buildings, Edinburgh, EH9 3JR, Scotland, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cyclacel Limited, James Lindsay Place, Dundee DD1 5JJ and Structural Biochemistry, The University of Edinburgh, Michael Swann Building, King's Buildings, Edinburgh, EH9 3JR, Scotland, UK","institution_ids":["https://openalex.org/I98677209"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113881172","display_name":"G. Griffiths","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I98677209","display_name":"University of Edinburgh","ror":"https://ror.org/01nrxwf90","country_code":"GB","type":"education","lineage":["https://openalex.org/I98677209"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Gary Griffiths","raw_affiliation_strings":["Cyclacel Limited, James Lindsay Place, Dundee DD1 5JJ and Structural Biochemistry, The University of Edinburgh, Michael Swann Building, King's Buildings, Edinburgh, EH9 3JR, Scotland, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cyclacel Limited, James Lindsay Place, Dundee DD1 5JJ and Structural Biochemistry, The University of Edinburgh, Michael Swann Building, King's Buildings, Edinburgh, EH9 3JR, Scotland, UK","institution_ids":["https://openalex.org/I98677209"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003452542","display_name":"Ian N. Fleming","orcid":"https://orcid.org/0000-0001-9505-6418","observed_orcids":["https://orcid.org/0000-0001-9505-6418"]},"institutions":[{"id":"https://openalex.org/I98677209","display_name":"University of Edinburgh","ror":"https://ror.org/01nrxwf90","country_code":"GB","type":"education","lineage":["https://openalex.org/I98677209"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ian Fleming","raw_affiliation_strings":["Cyclacel Limited, James Lindsay Place, Dundee DD1 5JJ and Structural Biochemistry, The University of Edinburgh, Michael Swann Building, King's Buildings, Edinburgh, EH9 3JR, Scotland, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cyclacel Limited, James Lindsay Place, Dundee DD1 5JJ and Structural Biochemistry, The University of Edinburgh, Michael Swann Building, King's Buildings, Edinburgh, EH9 3JR, Scotland, UK","institution_ids":["https://openalex.org/I98677209"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Simon Green","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I98677209","display_name":"University of Edinburgh","ror":"https://ror.org/01nrxwf90","country_code":"GB","type":"education","lineage":["https://openalex.org/I98677209"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Simon Green","raw_affiliation_strings":["Cyclacel Limited, James Lindsay Place, Dundee DD1 5JJ and Structural Biochemistry, The University of Edinburgh, Michael Swann Building, King's Buildings, Edinburgh, EH9 3JR, Scotland, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cyclacel Limited, James Lindsay Place, Dundee DD1 5JJ and Structural Biochemistry, The University of Edinburgh, Michael Swann Building, King's Buildings, Edinburgh, EH9 3JR, Scotland, UK","institution_ids":["https://openalex.org/I98677209"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079659005","display_name":"Iain W. McNae","orcid":"https://orcid.org/0000-0002-6312-7936","observed_orcids":["https://orcid.org/0000-0002-6312-7936"]},"institutions":[{"id":"https://openalex.org/I98677209","display_name":"University of Edinburgh","ror":"https://ror.org/01nrxwf90","country_code":"GB","type":"education","lineage":["https://openalex.org/I98677209"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Iain McNae","raw_affiliation_strings":["Cyclacel Limited, James Lindsay Place, Dundee DD1 5JJ and Structural Biochemistry, The University of Edinburgh, Michael Swann Building, King's Buildings, Edinburgh, EH9 3JR, Scotland, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cyclacel Limited, James Lindsay Place, Dundee DD1 5JJ and Structural Biochemistry, The University of Edinburgh, Michael Swann Building, King's Buildings, Edinburgh, EH9 3JR, Scotland, UK","institution_ids":["https://openalex.org/I98677209"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047231135","display_name":"Su\u2010Ying Wu","orcid":"https://orcid.org/0000-0003-2816-6961","observed_orcids":["https://orcid.org/0000-0003-2816-6961"]},"institutions":[{"id":"https://openalex.org/I98677209","display_name":"University of Edinburgh","ror":"https://ror.org/01nrxwf90","country_code":"GB","type":"education","lineage":["https://openalex.org/I98677209"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Su-Ying Wu","raw_affiliation_strings":["Cyclacel Limited, James Lindsay Place, Dundee DD1 5JJ and Structural Biochemistry, The University of Edinburgh, Michael Swann Building, King's Buildings, Edinburgh, EH9 3JR, Scotland, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cyclacel Limited, James Lindsay Place, Dundee DD1 5JJ and Structural Biochemistry, The University of Edinburgh, Michael Swann Building, King's Buildings, Edinburgh, EH9 3JR, Scotland, UK","institution_ids":["https://openalex.org/I98677209"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110026436","display_name":"Campbell McInnes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I98677209","display_name":"University of Edinburgh","ror":"https://ror.org/01nrxwf90","country_code":"GB","type":"education","lineage":["https://openalex.org/I98677209"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Campbell McInnes","raw_affiliation_strings":["Cyclacel Limited, James Lindsay Place, Dundee DD1 5JJ and Structural Biochemistry, The University of Edinburgh, Michael Swann Building, King's Buildings, Edinburgh, EH9 3JR, Scotland, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cyclacel Limited, James Lindsay Place, Dundee DD1 5JJ and Structural Biochemistry, The University of Edinburgh, Michael Swann Building, King's Buildings, Edinburgh, EH9 3JR, Scotland, UK","institution_ids":["https://openalex.org/I98677209"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081005693","display_name":"Daniella I. Zheleva","orcid":"https://orcid.org/0000-0002-1773-3687","observed_orcids":["https://orcid.org/0000-0002-1773-3687"]},"institutions":[{"id":"https://openalex.org/I98677209","display_name":"University of Edinburgh","ror":"https://ror.org/01nrxwf90","country_code":"GB","type":"education","lineage":["https://openalex.org/I98677209"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Daniella Zheleva","raw_affiliation_strings":["Cyclacel Limited, James Lindsay Place, Dundee DD1 5JJ and Structural Biochemistry, The University of Edinburgh, Michael Swann Building, King's Buildings, Edinburgh, EH9 3JR, Scotland, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cyclacel Limited, James Lindsay Place, Dundee DD1 5JJ and Structural Biochemistry, The University of Edinburgh, Michael Swann Building, King's Buildings, Edinburgh, EH9 3JR, Scotland, UK","institution_ids":["https://openalex.org/I98677209"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021205482","display_name":"Malcolm D. Walkinshaw","orcid":"https://orcid.org/0000-0001-5955-9325","observed_orcids":["https://orcid.org/0000-0001-5955-9325"]},"institutions":[{"id":"https://openalex.org/I98677209","display_name":"University of Edinburgh","ror":"https://ror.org/01nrxwf90","country_code":"GB","type":"education","lineage":["https://openalex.org/I98677209"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Malcolm D. Walkinshaw","raw_affiliation_strings":["Cyclacel Limited, James Lindsay Place, Dundee DD1 5JJ and Structural Biochemistry, The University of Edinburgh, Michael Swann Building, King's Buildings, Edinburgh, EH9 3JR, Scotland, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cyclacel Limited, James Lindsay Place, Dundee DD1 5JJ and Structural Biochemistry, The University of Edinburgh, Michael Swann Building, King's Buildings, Edinburgh, EH9 3JR, Scotland, UK","institution_ids":["https://openalex.org/I98677209"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5041852883","display_name":"Peter M. Fischer","orcid":"https://orcid.org/0000-0002-5866-9271","observed_orcids":["https://orcid.org/0000-0002-5866-9271"]},"institutions":[{"id":"https://openalex.org/I98677209","display_name":"University of Edinburgh","ror":"https://ror.org/01nrxwf90","country_code":"GB","type":"education","lineage":["https://openalex.org/I98677209"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Peter M. Fischer","raw_affiliation_strings":["Cyclacel Limited, James Lindsay Place, Dundee DD1 5JJ and Structural Biochemistry, The University of Edinburgh, Michael Swann Building, King's Buildings, Edinburgh, EH9 3JR, Scotland, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cyclacel Limited, James Lindsay Place, Dundee DD1 5JJ and Structural Biochemistry, The University of Edinburgh, Michael Swann Building, King's Buildings, Edinburgh, EH9 3JR, Scotland, UK","institution_ids":["https://openalex.org/I98677209"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5041852883"],"corresponding_institution_ids":["https://openalex.org/I98677209"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":6.0765,"has_fulltext":false,"cited_by_count":153,"citation_normalized_percentile":{"value":0.97592637,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"47","issue":"7","first_page":"1662","last_page":"1675"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.9814000129699707,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.9814000129699707,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.009600000455975533,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.0032999999821186066,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cdk2","display_name":"CDK2","score":0.7480000257492065},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.902999997138977},{"id":"https://openalex.org/keywords/structure-guided-design","display_name":"structure-guided design","score":0.8069999814033508},{"id":"https://openalex.org/keywords/atp-competitive-inhibitors","display_name":"ATP-competitive inhibitors","score":0.753000020980835},{"id":"https://openalex.org/keywords/cdk9-inhibition","display_name":"CDK9 inhibition","score":0.7440000176429749},{"id":"https://openalex.org/keywords/antiproliferative-activity","display_name":"antiproliferative activity","score":0.9629999995231628},{"id":"https://openalex.org/keywords/proapoptotic-effects","display_name":"proapoptotic effects","score":0.8820000290870667},{"id":"https://openalex.org/keywords/crystal-structure","display_name":"crystal structure","score":0.47200000286102295},{"id":"https://openalex.org/keywords/virtual-screening","display_name":"virtual screening","score":0.6000000238418579}],"concepts":[{"id":"https://openalex.org/C124320809","wikidata":"https://www.wikidata.org/wiki/Q46292","display_name":"Cyclin-dependent kinase","level":4,"score":0.8465992212295532},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8154778480529785},{"id":"https://openalex.org/C82495950","wikidata":"https://www.wikidata.org/wiki/Q14911732","display_name":"Cyclin-dependent kinase 2","level":4,"score":0.7579807043075562},{"id":"https://openalex.org/C2779321679","wikidata":"https://www.wikidata.org/wiki/Q207722","display_name":"Pyrimidine","level":2,"score":0.6704295873641968},{"id":"https://openalex.org/C2778298596","wikidata":"https://www.wikidata.org/wiki/Q17143494","display_name":"CDK inhibitor","level":5,"score":0.6295086145401001},{"id":"https://openalex.org/C193042331","wikidata":"https://www.wikidata.org/wiki/Q1772003","display_name":"Structure\u2013activity relationship","level":3,"score":0.5439086556434631},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.5109075903892517},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.47583508491516113},{"id":"https://openalex.org/C57992300","wikidata":"https://www.wikidata.org/wiki/Q2066956","display_name":"Potency","level":3,"score":0.42258283495903015},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.42028287053108215},{"id":"https://openalex.org/C161624437","wikidata":"https://www.wikidata.org/wiki/Q1988322","display_name":"Small molecule","level":2,"score":0.42025476694107056},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2773582935333252},{"id":"https://openalex.org/C97029542","wikidata":"https://www.wikidata.org/wiki/Q281417","display_name":"Protein kinase A","level":3,"score":0.2620604336261749},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.2027612030506134},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.13845154643058777},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.11448246240615845}],"mesh":[{"descriptor_ui":"D000814","descriptor_name":"Aniline Compounds","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D000814","descriptor_name":"Aniline Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000814","descriptor_name":"Aniline Compounds","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D002453","descriptor_name":"Cell Cycle","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018360","descriptor_name":"Crystallography, X-Ray","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D042846","descriptor_name":"CDC2-CDC28 Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D042863","descriptor_name":"Cyclin-Dependent Kinase 9","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051357","descriptor_name":"Cyclin-Dependent Kinase 2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1021/jm0309957","doi":"https://doi.org/10.1021/jm0309957","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm0309957","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:15027857","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15027857","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"},{"id":"pmh:oai:oro.open.ac.uk:2304","doi":null,"is_oa":false,"landing_page_url":"https://oro.open.ac.uk/2304/","pdf_url":null,"source":{"id":"https://openalex.org/S4306401187","display_name":"Open Research Online (The Open University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I204136569","host_organization_name":"The Open University","host_organization_lineage":["https://openalex.org/I204136569"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"PeerReviewed"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8199999928474426,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W1544564404","https://openalex.org/W1552046925","https://openalex.org/W1563954963","https://openalex.org/W1942297882","https://openalex.org/W1968091558","https://openalex.org/W1978985435","https://openalex.org/W1990750564","https://openalex.org/W2006046129","https://openalex.org/W2007618242","https://openalex.org/W2016329254","https://openalex.org/W2031203111","https://openalex.org/W2036804890","https://openalex.org/W2038407368","https://openalex.org/W2039771541","https://openalex.org/W2041254889","https://openalex.org/W2053453319","https://openalex.org/W2064028836","https://openalex.org/W2066123607","https://openalex.org/W2077165680","https://openalex.org/W2084810833","https://openalex.org/W2088120691","https://openalex.org/W2097493124","https://openalex.org/W2098203835","https://openalex.org/W2113604152","https://openalex.org/W2118699566","https://openalex.org/W2152028923","https://openalex.org/W2155230284","https://openalex.org/W4323284058"],"related_works":["https://openalex.org/W2078218463","https://openalex.org/W2075318470","https://openalex.org/W1861229172","https://openalex.org/W2068797937","https://openalex.org/W2110793625","https://openalex.org/W2078412962","https://openalex.org/W4315434941","https://openalex.org/W2175404475","https://openalex.org/W2793790325","https://openalex.org/W2133365508"],"abstract_inverted_index":{"Following":[0],"the":[1,33,43,46,51,58,100,111,118,122],"identification":[2],"through":[3],"virtual":[4],"screening":[5],"of":[6,12,36,38,60,79],"4-(2,4-dimethyl-thiazol-5-yl)pyrimidin-2-ylamines":[7],"as":[8],"moderately":[9],"potent":[10,113],"inhibitors":[11],"cyclin-dependent":[13],"kinase-2":[14],"(CDK2),":[15],"a":[16],"CDK":[17],"inhibitor":[18,115],"analogue":[19],"program":[20],"was":[21],"initiated.":[22],"The":[23],"first":[24],"aims":[25],"were":[26],"to":[27,31,57,98],"optimize":[28],"potency":[29],"and":[30,50,93,125,133],"evaluate":[32],"cellular":[34,131],"mode":[35],"action":[37],"lead":[39],"candidate":[40],"molecules.":[41],"Here":[42],"synthetic":[44],"chemistry,":[45],"structure-guided":[47],"design":[48],"approach,":[49],"structure-activity":[52],"relationships":[53],"(SARs)":[54],"that":[55,108,121],"led":[56],"discovery":[59],"2-anilino-4-(thiazol-5-yl)pyrimidine":[61],"ATP-antagonistic":[62],"CDK2":[63,90,114,132],"inhibitors,":[64],"many":[65],"with":[66,89,130],"very":[67],"low":[68],"nM":[69],"K(i)s":[70],"against":[71],"CDK2,":[72],"are":[73,91,96,106,128],"reported.":[74],"Furthermore,":[75],"X-ray":[76],"crystal":[77],"structures":[78,95],"four":[80],"representative":[81],"analogues":[82],"from":[83,117],"our":[84],"chemical":[85],"series":[86],"in":[87],"complex":[88],"presented,":[92],"these":[94],"used":[97],"rationalize":[99],"observed":[101,123],"biochemical":[102],"SARs.":[103],"Finally":[104],"results":[105],"reported":[107],"show,":[109],"using":[110],"most":[112],"compound":[116],"current":[119],"series,":[120],"antiproliferative":[124],"proapoptotic":[126],"effects":[127],"consistent":[129],"CDK9":[134],"inhibition.":[135]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":9},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":13},{"year":2014,"cited_by_count":10},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}